Cargando…

Lipids at the Nexus between Cerebrovascular Disease and Vascular Dementia: The Impact of HDL-Cholesterol and Ceramides

Cerebrovascular diseases and the subsequent brain hypoperfusion are at the basis of vascular dementia. Dyslipidemia, marked by an increase in circulating levels of triglycerides and LDL-cholesterol and a parallel decrease in HDL-cholesterol, in turn, is pivotal in promoting atherosclerosis which rep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sergi, Domenico, Zauli, Enrico, Tisato, Veronica, Secchiero, Paola, Zauli, Giorgio, Cervellati, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002119/ https://www.ncbi.nlm.nih.gov/pubmed/36901834 http://dx.doi.org/10.3390/ijms24054403

Ejemplares similares

Low Circulating TRAIL Levels Are Associated with Increase of Resistin and Lipocalin-2/ngal Adipokines in Postmenopausal Women
por: Tisato, Veronica, et al.
Publicado: (2017)

Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients
por: Zauli, Giorgio, et al.
Publicado: (2020)

Clinical perspectives of TRAIL: insights into central nervous system disorders
por: Tisato, Veronica, et al.
Publicado: (2016)

MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
por: Tisato, Veronica, et al.
Publicado: (2017)

p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics)
por: Milani, Daniela, et al.
Publicado: (2022)

Association of Serum Tumor Necrosis Factor-Related Apoptosis Inducing Ligand with Body Fat Distribution as Assessed by Dual X-Rays Absorptiometry
por: Cervellati, Carlo, et al.
Publicado: (2014)

Palmitic Acid Induced a Long-Lasting Lipotoxic Insult in Human Retinal Pigment Epithelial Cells, which Is Partially Counteracted by TRAIL
por: Sergi, Domenico, et al.
Publicado: (2022)

TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?
por: Bernardi, Stella, et al.
Publicado: (2019)

Inflammation and Cardiovascular Cross Talk in Ischemic Vascular Diseases
por: Zauli, Giorgio, et al.
Publicado: (2017)

Serum TRAIL levels increase shortly after insulin therapy and metabolic stabilization in children with type 1 diabetes mellitus
por: Tornese, Gianluca, et al.
Publicado: (2015)

COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-Chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
por: Gemmati, Donato, et al.
Publicado: (2020)

TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress
por: Tisato, Veronica, et al.
Publicado: (2018)

TRAIL/DR5 pathway promotes AKT phosphorylation, skeletal muscle differentiation, and glucose uptake
por: Toffoli, Barbara, et al.
Publicado: (2021)

Sex/Gender-Specific Imbalance in CVD: Could Physical Activity Help to Improve Clinical Outcome Targeting CVD Molecular Mechanisms in Women?
por: Vaccarezza, Mauro, et al.
Publicado: (2020)

Modulation of Circulating Cytokine-Chemokine Profile in Patients Affected by Chronic Venous Insufficiency Undergoing Surgical Hemodynamic Correction
por: Tisato, Veronica, et al.
Publicado: (2014)

GM-CSF Exhibits Anti-Inflammatory Activity on Endothelial Cells Derived from Chronic Venous Disease Patients
por: Tisato, Veronica, et al.
Publicado: (2013)

Inhibitory Effect of Natural Anti-Inflammatory Compounds on Cytokines Released by Chronic Venous Disease Patient-Derived Endothelial Cells
por: Tisato, Veronica, et al.
Publicado: (2013)

Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy
por: Tisato, Veronica, et al.
Publicado: (2015)

In Vitro Endothelial Cell Proliferation Assay Reveals Distinct Levels of Proangiogenic Cytokines Characterizing Sera of Healthy Subjects and of Patients with Heart Failure
por: Voltan, Rebecca, et al.
Publicado: (2014)

The γ-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells
por: Secchiero, Paola, et al.
Publicado: (2017)

miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach
por: Salvatori, Francesca, et al.
Publicado: (2023)

Soluble TRAIL does not impair the anti-osteoclastic activity of osteoprotegerin
por: Zauli, Giorgio, et al.
Publicado: (2008)

Endothelial Cells Obtained from Patients Affected by Chronic Venous Disease Exhibit a Pro-Inflammatory Phenotype
por: Tisato, Veronica, et al.
Publicado: (2012)

Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model
por: Tisato, Veronica, et al.
Publicado: (2014)

Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol
por: Brombo, Gloria, et al.
Publicado: (2013)

Maternal Haplotypes in DHFR Promoter and MTHFR Gene in Tuning Childhood Acute Lymphoblastic Leukemia Onset-Latency: Genetic/Epigenetic Mother/Child Dyad Study (GEMCDS)
por: Tisato, Veronica, et al.
Publicado: (2019)

Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors
por: Rimondi, Erika, et al.
Publicado: (2021)

Cell-Based Therapies for Diabetic Complications
por: Bernardi, Stella, et al.
Publicado: (2012)

Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection
por: Romani, Arianna, et al.
Publicado: (2023)

Ceramide in cerebrovascular diseases
por: Yuan, Huiqi, et al.
Publicado: (2023)

TRAIL Modulates the Immune System and Protects against the Development of Diabetes
por: Bossi, Fleur, et al.
Publicado: (2015)

Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells
por: Lodi, Giada, et al.
Publicado: (2022)

Adipocyte Ceramides—The Nexus of Inflammation and Metabolic Disease
por: Chaurasia, Bhagirath, et al.
Publicado: (2020)

Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease
por: Arcidiacono, Maria Vittoria, et al.
Publicado: (2018)

Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation
por: Zauli, Giorgio, et al.
Publicado: (2022)

Host genetics impact on SARS-CoV-2 vaccine-induced immunoglobulin levels and dynamics: The role of TP53, ABO, APOE, ACE2, HLA-A, and CRP genes
por: Gemmati, Donato, et al.
Publicado: (2022)

Paraoxonase-1 and Other HDL Accessory Proteins in Neurological Diseases
por: Marsillach, Judit, et al.
Publicado: (2021)

Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction
por: Secchiero, Paola, et al.
Publicado: (2009)

Treatment With Recombinant Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Alleviates the Severity of Streptozotocin-Induced Diabetes
por: Zauli, Giorgio, et al.
Publicado: (2010)

In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome
por: Campioni, Diana, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f55dg7jfa5or45redpo3hmbl1l